Citigroup’s Arvinas ARVN Stock Holding History

Citigroup’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-67,500	Closed	-$2.77M	–	7584
2019 Q4	$2.77M	Buy	+67,500	New	+$1.98M	﹤0.01%	2636

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's ARVN Position: Q2 2026 in Review

Citigroup increased its Arvinas (ARVN) stake by 132% in Q2 2026, buying an estimated $309K and bringing the position to 58,263 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #3914.

Citigroup first reported a position in ARVN in Q3 2018 and has held it in 32 quarters since. The position peaked at $5.71M in Q4 2023. 201 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

Citigroup held 58,263 shares of Arvinas worth $484K as of Q2 2026.
Citigroup bought 33,141 Arvinas shares in Q2 2026, an estimated $309K.
Arvinas made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3914 holding.
Citigroup first reported a position in Arvinas in Q3 2018 and has held it in 32 quarters since.
Citigroup's Arvinas position peaked at $5.71M in Q4 2023.
201 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.